POLINI, BEATRICE
 Distribuzione geografica
Continente #
NA - Nord America 3.585
EU - Europa 2.073
AS - Asia 1.994
SA - Sud America 365
AF - Africa 94
OC - Oceania 21
Totale 8.132
Nazione #
US - Stati Uniti d'America 3.493
IT - Italia 1.078
SG - Singapore 660
CN - Cina 605
HK - Hong Kong 342
BR - Brasile 302
DE - Germania 227
SE - Svezia 186
VN - Vietnam 117
BG - Bulgaria 95
GB - Regno Unito 83
FI - Finlandia 66
FR - Francia 65
AT - Austria 64
CA - Canada 61
IN - India 52
RU - Federazione Russa 47
KR - Corea 36
PL - Polonia 33
JP - Giappone 32
TR - Turchia 32
CI - Costa d'Avorio 23
NL - Olanda 21
AR - Argentina 20
MX - Messico 20
AU - Australia 19
BD - Bangladesh 16
ES - Italia 16
IR - Iran 15
MA - Marocco 14
SN - Senegal 13
ZA - Sudafrica 13
CZ - Repubblica Ceca 12
PK - Pakistan 12
IE - Irlanda 10
IL - Israele 10
IQ - Iraq 10
NG - Nigeria 9
SA - Arabia Saudita 9
BE - Belgio 8
CO - Colombia 8
EC - Ecuador 8
PE - Perù 8
PT - Portogallo 8
RO - Romania 8
VE - Venezuela 8
KE - Kenya 7
CH - Svizzera 6
HU - Ungheria 6
TW - Taiwan 6
UA - Ucraina 6
AE - Emirati Arabi Uniti 5
DZ - Algeria 4
EG - Egitto 4
ID - Indonesia 4
KZ - Kazakistan 4
LT - Lituania 4
MK - Macedonia 4
PH - Filippine 4
AL - Albania 3
AZ - Azerbaigian 3
NO - Norvegia 3
PY - Paraguay 3
UY - Uruguay 3
BY - Bielorussia 2
CL - Cile 2
CR - Costa Rica 2
GA - Gabon 2
JM - Giamaica 2
KG - Kirghizistan 2
LI - Liechtenstein 2
LV - Lettonia 2
MY - Malesia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TN - Tunisia 2
UZ - Uzbekistan 2
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
DK - Danimarca 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
GY - Guiana 1
IS - Islanda 1
JO - Giordania 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MN - Mongolia 1
NI - Nicaragua 1
PS - Palestinian Territory 1
QA - Qatar 1
Totale 8.126
Città #
Dallas 625
Ashburn 442
Singapore 354
Hong Kong 337
Fairfield 227
Serra 219
Santa Clara 206
Woodbridge 201
Chandler 160
Pisa 153
Shanghai 121
Beijing 106
Houston 106
New York 99
Sofia 95
Wilmington 94
Los Angeles 90
Milan 87
Munich 81
Boardman 73
Seattle 73
Cambridge 67
Ann Arbor 66
Princeton 58
Hefei 55
Vienna 54
Lawrence 43
Medford 40
Buffalo 37
Rome 37
Lucca 36
Florence 35
Seoul 32
São Paulo 32
Ho Chi Minh City 30
London 30
Turku 29
Frankfurt am Main 28
Warsaw 27
Ottawa 26
Chicago 24
Redwood City 24
Abidjan 23
Livorno 23
Pistoia 23
Ogden 21
Dong Ket 20
Hanoi 20
Redondo Beach 20
Tokyo 20
Istanbul 19
Dearborn 17
Des Moines 17
Guangzhou 17
Marseille 17
Rio de Janeiro 16
Helsinki 15
Montreal 15
Nanjing 15
Belo Horizonte 13
Casablanca 13
Dakar 13
Pescara 13
Fuzhou 12
Boulder 11
Lappeenranta 11
Norwalk 11
Stockholm 11
Brooklyn 10
Denver 10
Genoa 10
San Diego 10
Carrara 9
Cascina 9
Dublin 9
Hyderabad 9
Johannesburg 9
Lagos 9
Nuremberg 9
Toronto 9
Boston 8
Changsha 8
Council Bluffs 8
Mexico City 8
Nürnberg 8
Pessac 8
Phoenix 8
Quanzhou 8
Ankara 7
Bologna 7
Braga 7
Brasília 7
Brussels 7
Nairobi 7
Panorama City 7
Salt Lake City 7
San Francisco 7
Trieste 7
Wuhan 7
Chennai 6
Totale 5.444
Nome #
Cytotoxic Activity of Oleocanthal Isolated from Virgin Olive Oil on Human Melanoma Cells 339
Anticancer activity of euplotin C, isolated from the marine ciliate euplotes crassus, against human melanoma cells 254
Circulating MicroRNAs in Cutaneous Melanoma Diagnosis and Prognosis 247
Circulating cell-free microRNAs in cutaneous melanoma staging and recurrence or survival prognosis 228
Cholinesterase-like organocatalysis by imidazole and imidazole-bearing molecules 227
Oleocanthal and oleacein contribute to the in vitro therapeutic potential of extra virgin oil-derived extracts in non-melanoma skin cancer 227
Diclofenac-Derived Hybrids for Treatment of Actinic Keratosis and Squamous Cell Carcinoma 191
The Extra-Virgin Olive Oil Polyphenols Oleocanthal and Oleacein Counteract Inflammation-Related Gene and miRNA Expression in Adipocytes by Attenuating NF-κB Activation 184
Identification of plasma microRNAs as new potential biomarkers with high diagnostic power in human cutaneous melanoma. 181
Tumor-promoting effects of cannabinoid receptor type 1 in human melanoma cells. 180
Complexing the Marine Sesquiterpene Euplotin C by Means of Cyclodextrin-Based Nanosponges: A Preliminary Investigation 176
Role of miR-34a as biomarker and therapeutic agent in cutaneous melanoma 175
Extracellular Vesicles Induce Nuclear Factor-κB Activation and Interleukin-8 Synthesis through miRNA-191-5p Contributing to Inflammatory Processes: Potential Implications in the Pathogenesis of Chronic Obstructive Pulmonary Disease 171
pH-responsive nanostructures based on surface active fatty acid-protic ionic liquids for imiquimod delivery in skin cancer topical therapy 171
The phenolic compounds tyrosol and hydroxytyrosol counteract liver fibrogenesis via the transcriptional modulation of NADPH oxidases and oxidative stress-related miRNAs 168
Identification of five circulating microRNAs with high diagnostic values in cutaneous melanoma 167
Apolipoprotein E Polymorphism and Oxidative Stress in Human Peripheral Blood Cells: Can Physical Activity Reactivate the Proteasome System through Epigenetic Mechanisms? 167
Design, Synthesis, and Biological Activity of New CB2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic Ligands 163
Potential relationship between the expression of Cx26/Cx43 and the BRAF mutation status in human melanoma cells 161
New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2 159
Circulating microRNAs as biomarkers for early diagnosis of cutaneous melanoma 152
Delivery of thyronamines (Tams) to the brain: A preliminary study 151
SG‐2: A SYNTHETIC ANALOG OF THYROID HORMONE METABOLITE 3‐IODOTHYRONAMINE (T1AM), PREVENTS β‐AMYLOID NEUROTOXICITY IN VITRO 145
Expression analysis of muscle-specific miRNAs in plasma-derived extracellular vesicles from patients with chronic obstructive pulmonary disease 143
Topical application of silymarin enhances cutaneous wound healing in rats 134
EGFR-TKIs in non-small-cell lung cancer: Focus on clinical pharmacology and mechanisms of resistance 132
Evaluation of circulating microRNAs as diagnostic circulating biomarkers in cutaneous melanoma 129
Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy 129
The endocannabinoid system dual-target ligand N-cycloheptyl-1,2-dihydro-5-bromo-1-(4-fluorobenzyl)-6-methyl-2-oxo-pyridine-3-carboxamide improves disease severity in a mouse model of multiple sclerosis 123
Sex Differences in Blood Accumulation of Neurodegenerative-Related Proteins and Antioxidant Responses to Regular Physical Exercise 122
Hydroxytyrosol modulates adipocyte gene and mirna expression under inflammatory condition 121
The role of cannabinoids in bone metabolism: A new perspective for bone disorders 120
miRNA Modulation and Antitumor Activity by the Extra-Virgin Olive Oil Polyphenol Oleacein in Human Melanoma Cells 119
Tailoring of silica-based nanoporous pod by spermidine multi-activity 118
The Extra Virgin Olive Oil Polyphenol Oleocanthal Exerts Antifibrotic Effects in the Liver 113
Performance in Behavioral Testing in an Animal Model of Post-Surgical Hypoparathyroidism 110
Nicotine Metabolite Ratio in Smokers: A Real World Experience 109
Discovery of pyridoquinoxaline-based new P-gp inhibitors as coadjutant against Multi Drug Resistance in cancer 108
Nutraceutical Molecules Slow Down Retinal Degeneration, in Tvrm4 Mice a Model of Retinitis Pigmentosa, by Genetic Modulation of Anti-Oxidant Pathway 108
The Interplay between Cannabinoid Receptors and Microglia in the Pathophysiology of Alzheimer's Disease 103
8.1.4 – Biological Vesicles and Platforms – Cyclodextrin-based platforms as RNA delivery systems 100
Novel Orthosteric/Allosteric Ligands of Cannabinoid Receptors: An Unexpected Pharmacological Profile 94
A Proteomic Approach Identified TFEB as a Key Player in the Protective Action of Novel CB2R Bitopic Ligand FD22a against the Deleterious Effects Induced by β-Amyloid in Glial Cells 92
Role of miR-193a as therapeutic agent and biomarker in cutaneous melanoma 91
Design, synthesis and biological evaluation of novel orthosteric-allosteric ligands of the cannabinoid receptor type 2 (CB2R) 89
null 86
Tumor suppressor role of hsa-mir-193a-3p and-5p in cutaneous melanoma 86
null 85
null 84
Identification of a Thyroid Hormone Derivative as a Pleiotropic Agent for the Treatment of Alzheimer's Disease 84
Contribution of irisin pathway in protective effects of mandarin juice (Citrus reticulata Blanco) on metabolic syndrome in rats fed with high fat diet 82
Intake of Natural Compounds and Circulating microRNA Expression Levels: Their Relationship Investigated in Healthy Subjects With Different Dietary Habits 79
MIR-193A MIMICS AS NEW POTENTIAL THERAPEUTIC AGENTS IN CUTANEOUS MELANOMA 78
null 76
T1AM/TAAR1 System Reduces Inflammatory Response and β-Amyloid Toxicity in Human Microglial HMC3 Cell Line 76
Characterization of the role of the endocannabinoid system in human melanoma cells 74
Editorial: Non-Coding RNAs as Mediators of the Activity of Natural Compounds 74
Beta-Caryophyllene, a Cannabinoid Receptor Type 2 Selective Agonist, in Emotional and Cognitive Disorders 71
Pro-apoptotic Activity of the Marine Sponge Dactylospongia elegans Metabolites Pelorol and 5-epi-ilimaquinone on Human 501Mel Melanoma Cells 68
β-Cyclodextrin nanosponges for the ocular delivery of therapeutic Micro-RNA in a Mouse model of retinitis Pigmentosa: A proof of concept study 67
Tanshinone IIA and Cryptotanshinone Counteract Inflammation by Regulating Gene and miRNA Expression in Human SGBS Adipocytes. 66
Set-up experiments for microRNAs characterization in plasma and circulating tumor cells derived from patients with cutaneous melanoma 64
Novel Thyroid Hormone Receptor-β Agonist TG68 Exerts Anti-Inflammatory, Lipid-Lowering and Anxiolytic Effects in a High-Fat Diet (HFD) Mouse Model of Obesity 53
Pharmacological Activities of Extracts and Compounds Isolated from Mediterranean Sponge Sources 51
ROLE OF THE CB1 CANNABINOID RECEPTOR IN BRAFV600E MELANOMA CELLS AND STEM-LIKE CELLS 50
Positive allosteric modulation of CB1 and CB2 cannabinoid receptors enhances the neuroprotective activity of a dual CB1R/CB2R orthosteric agonist 40
null 40
Totale 8.425
Categoria #
all - tutte 24.438
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.438


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021402 0 0 0 0 0 66 49 49 74 80 35 49
2021/2022619 24 58 29 25 75 79 32 30 38 33 56 140
2022/2023778 105 103 73 33 73 93 12 48 109 4 39 86
2023/2024745 65 68 89 62 97 64 89 22 14 29 58 88
2024/20252.098 25 69 33 122 154 246 186 100 201 277 222 463
2025/20262.204 274 404 590 397 359 180 0 0 0 0 0 0
Totale 8.425